Design, synthesis and evaluation of 5-chloro-6-methylaurone derivatives as potential anti-cancer agents. 2023

Mehak Saba Lone, and Syed Ayaz Nabi, and Farhat Ramzan Wani, and Manika Garg, and Shaista Amin, and Mohammed Samim, and Syed Shafi, and Farah Khan, and Kalim Javed
Department of Chemistry, School of Chemical and Life Sciences (SCLS), Jamia Hamdard, New Delhi, India.

A series of novel 5-chloro-6-methylaurone derivatives (6a-p) were synthesized and characterized by various spectroscopic techniques. The synthesized compounds were tested for anticancer activity against 60-human cancer cell line panel derived from nine cancer types at NCI, Bethesda, USA. Among the synthesized compounds, six compounds (6e, 6f, 6h, 6i, 6k and 6 m) exhibited growth inhibition and cytotoxic activity against various human cancer cell lines in one-dose data. The most potent compound among the series, 6i was active against 55 out of 60 human cancer cell lines. Compound 6i showed remarkable % growth inhibition and cytotoxicity against various cancer cell lines exhibiting % GI in the range 36.05-199.03. The compound 6i was further evaluated for five dose assay and exhibited GI50 1.90 µM and 2.70 µM against melanoma and breast cancer cell lines respectively. Further evaluation of 6i for five-dose assay exhibited a diverse spectrum of anti-cancer activity towards all the 60 human cancer cell line panel with the selectivity index ratio ranging 0.854-1.42  and 0.66-1.35  for GI50 and TGI respectively. Based on one-dose and five-dose data compound 6i was further evaluated for cell apoptosis against MDA-MB-468 breast cancer cell line and was found to induce early apoptosis in cells explaining its mode of action. The in-silico studies for the synthesized compounds as LSD1 inhibitors (2H94) have shown better docking score and binding energy comparable to vafidemstat. All the compounds followed Lipinski rule of five. These findings concluded that the compound 6i could lead to the development of a promising therapeutic anticancer agent.

UI MeSH Term Description Entries
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular
D062105 Molecular Docking Simulation A computer simulation technique that is used to model the interaction between two molecules. Typically the docking simulation measures the interactions of a small molecule or ligand with a part of a larger molecule such as a protein. Molecular Docking,Molecular Docking Simulations,Molecular Docking Analysis,Analysis, Molecular Docking,Docking Analysis, Molecular,Docking Simulation, Molecular,Docking, Molecular,Molecular Docking Analyses,Molecular Dockings,Simulation, Molecular Docking

Related Publications

Mehak Saba Lone, and Syed Ayaz Nabi, and Farhat Ramzan Wani, and Manika Garg, and Shaista Amin, and Mohammed Samim, and Syed Shafi, and Farah Khan, and Kalim Javed
March 2006, Bioorganic & medicinal chemistry letters,
Mehak Saba Lone, and Syed Ayaz Nabi, and Farhat Ramzan Wani, and Manika Garg, and Shaista Amin, and Mohammed Samim, and Syed Shafi, and Farah Khan, and Kalim Javed
August 2012, Journal of enzyme inhibition and medicinal chemistry,
Mehak Saba Lone, and Syed Ayaz Nabi, and Farhat Ramzan Wani, and Manika Garg, and Shaista Amin, and Mohammed Samim, and Syed Shafi, and Farah Khan, and Kalim Javed
October 2022, International journal of molecular sciences,
Mehak Saba Lone, and Syed Ayaz Nabi, and Farhat Ramzan Wani, and Manika Garg, and Shaista Amin, and Mohammed Samim, and Syed Shafi, and Farah Khan, and Kalim Javed
September 2014, European journal of medicinal chemistry,
Mehak Saba Lone, and Syed Ayaz Nabi, and Farhat Ramzan Wani, and Manika Garg, and Shaista Amin, and Mohammed Samim, and Syed Shafi, and Farah Khan, and Kalim Javed
August 2020, Natural product research,
Mehak Saba Lone, and Syed Ayaz Nabi, and Farhat Ramzan Wani, and Manika Garg, and Shaista Amin, and Mohammed Samim, and Syed Shafi, and Farah Khan, and Kalim Javed
June 2017, Molecules (Basel, Switzerland),
Mehak Saba Lone, and Syed Ayaz Nabi, and Farhat Ramzan Wani, and Manika Garg, and Shaista Amin, and Mohammed Samim, and Syed Shafi, and Farah Khan, and Kalim Javed
August 2021, RSC medicinal chemistry,
Mehak Saba Lone, and Syed Ayaz Nabi, and Farhat Ramzan Wani, and Manika Garg, and Shaista Amin, and Mohammed Samim, and Syed Shafi, and Farah Khan, and Kalim Javed
January 2021, Anti-cancer agents in medicinal chemistry,
Mehak Saba Lone, and Syed Ayaz Nabi, and Farhat Ramzan Wani, and Manika Garg, and Shaista Amin, and Mohammed Samim, and Syed Shafi, and Farah Khan, and Kalim Javed
July 2018, MedChemComm,
Mehak Saba Lone, and Syed Ayaz Nabi, and Farhat Ramzan Wani, and Manika Garg, and Shaista Amin, and Mohammed Samim, and Syed Shafi, and Farah Khan, and Kalim Javed
April 2018, European journal of medicinal chemistry,
Copied contents to your clipboard!